TSX defers consideration of CanniMed Therapeutics shareholder rights plan

CanniMed Therapeutics Inc. says it has been notified that the Toronto Stock Exchange will defer consideration of a shareholder rights plan adopted by the company in a bid to defend itself against a hostile takeover offer by Aurora Cannabis Inc.
The Saskatoon-based company says the TSX normally defers acceptance of shareholder rights plans adopted in response to a specific take-over bid.
It says the TSX will defer the rights plans until the TSX is satisfied that the Ontario Securities Commission